MTA1 is generally overexpressed in tumors, and also in colorectal cancer (Figure 1A), and the MTA1 expression level is negatively correlated with the overall survival of the patients in the colorectal cancer cohort (Figure 1B). This evidence concerns the gene MTA1 and colorectal cancer.